jump to content

Migraine Study — Compensation $318.00

A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute…

The study periods will consist of Visit 1 (Screening) where eligibility assessment and randomization of eligible subjects will occur. The Outpatient Treatment Period will last up to 60 days and Visit 2 (End of Study) will occur either within 10 days after the dose of investigational treatment is administered or the
Outpatient Treatment Period has ended.


Compensation $318.00

More Nearby Studies

This study is investigating the balance of good and bad bacteria (the microbiome) in…

$100 & Microbiota Report

Expansion of the Quadruple Aim to include acute care nurses perceptions of how the…

.Outcomes Report

The goal of this study is to determine the impact of when you eat and melatonin…

compensation up to $2,500

We are currently recruiting men and women between the ages of 18-30 for our study…

up to $115

Your password must contain:
6 or more characters
Upper and lowercase letters
At least one number